Patents by Inventor Mark Thomas Boyd

Mark Thomas Boyd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100286362
    Abstract: Isolated nucleic acid sequences encoding mammalian MDM2 binding protein and polypeptide sequences for the mammalian MDM2 binding protein are provided. Also provided are vectors containing these nucleic acid sequences, host cells which express these proteins and antibodies targeted to these proteins. In addition, methods and compositions for modulating the G1 phase of the cell cycle via altering expression and/or activity of a mammalian MDM2 binding protein are provided.
    Type: Application
    Filed: April 14, 2010
    Publication date: November 11, 2010
    Inventors: Mark Thomas Boyd, Dale Stewart Hainee, Nikolina Vlatkovle
  • Patent number: 7732577
    Abstract: Isolated nucleic acid sequences encoding mammalian MDM2 binding protein and polypeptide sequences for the mammalian MDM2 binding protein are provided. Also provided are vectors containing these nucleic acid sequences, host cells which express these proteins and antibodies targeted to these proteins. In addition, methods and compositions for modulating the G1 phase of the cell cycle via altering expression and/or activity of a mammalian MDM2 binding protein are provided.
    Type: Grant
    Filed: October 23, 2007
    Date of Patent: June 8, 2010
    Assignee: Philadelphia Health and Education Corporation
    Inventors: Mark Thomas Boyd, Dale Stewart Haines, Nikolina Vlatkovic
  • Publication number: 20090017538
    Abstract: Isolated nucleic acid sequences encoding mammalian binding protein and polypeptide sequences for the mammalian MDM2 binding protein are provided. Also provided are vectors containing these nucleic acid sequences, host cells which express these proteins and antibodies targeted to these proteins. In addition, methods and compositions for modulating the G1 phase of the cell cycle via altering expression and/or activity of a mammalian MDM2 binding protein are provided.
    Type: Application
    Filed: October 23, 2007
    Publication date: January 15, 2009
    Inventors: Mark Thomas Boyd, Dale Stewart Haines, Nikolina Vlatkovic
  • Patent number: 7304142
    Abstract: Isolated nucleic acid sequences encoding mammalian MDM2 binding protein and polypeptide sequences for the mammalian MDM2 binding protein are provided. Also provided are vectors containing these nucleic acid sequences, host cells which express these proteins and antibodies targeted to these proteins. In addition, methods and compositions for modulating the G1 phase of the cell cycle via altering expression and/or activity of a mammalian MDM2 binding protein are provided.
    Type: Grant
    Filed: January 5, 2007
    Date of Patent: December 4, 2007
    Assignee: Philadelphia, Health and Education Corporation
    Inventors: Mark Thomas Boyd, Dale Stewart Haines, Nikolina Vlatkovic
  • Patent number: 7166712
    Abstract: Isolated nucleic acid sequences encoding mammalian MDM2 binding protein and polypeptide sequences for the mammalian MDM2 binding protein are provided. Also provided are vectors containing these nucleic acid sequences, host cells which express these proteins and antibodies targeted to these proteins. In addition, methods and compositions for modulating the G1 phase of the cell cycle via altering expression and/or activity of a mammalian MDM2 binding protein are provided.
    Type: Grant
    Filed: July 12, 2001
    Date of Patent: January 23, 2007
    Assignee: Philadelphia, Health and Education Corporation
    Inventors: Mark Thomas Boyd, Dale Stewart Haines, Nikolina Vlatkovic